Role of radiomics in staging liver fibrosis: a meta-analysis

Xiao-min Wang,Xiao-jing Zhang

DOI: https://doi.org/10.1186/s12880-024-01272-x

IF: 2.7949

2024-04-13

BMC Medical Imaging

Abstract:Fibrosis has important pathoetiological and prognostic roles in chronic liver disease. This study evaluates the role of radiomics in staging liver fibrosis.

radiology, nuclear medicine & medical imaging

What problem does this paper attempt to address?

Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker

Jincheng Wang,Shengnan Tang,Yingfan Mao,Jin Wu,Shanshan Xu,Qi Yue,Jun Chen,Jian He,Yin Yin

DOI: https://doi.org/10.1007/s12072-022-10326-7

IF: 9.029

2022-03-28

Hepatology International

Abstract:Abstract Background To establish and validate a radiomics-based model for staging liver fibrosis at contrast-enhanced CT images. Materials and methods This retrospective study developed two radiomics-based models (R-score: radiomics signature; R-fibrosis: integrate radiomic and serum variables) in a training cohort of 332 patients (median age, 59 years; interquartile range, 51–67 years; 256 men) with biopsy-proven liver fibrosis who underwent contrast-enhanced CT between January 2017 and December 2020. Radiomic features were extracted from non-contrast, arterial and portal phase CT images and selected using the least absolute shrinkage and selection operator (LASSO) logistic regression to differentiate stage F3–F4 from stage F0–F2. Optimal cutoffs to diagnose significant fibrosis (stage F2–F4), advanced fibrosis (stage F3–F4) and cirrhosis (stage F4) were determined by receiver operating characteristic curve analysis. Diagnostic performance was evaluated by area under the curve, Obuchowski index, calibrations and decision curve analysis. An internal validation was conducted in 111 randomly assigned patients (median age, 58 years; interquartile range, 49–66 years; 89 men). Results In the validation cohort, R-score and R-fibrosis (Obuchowski index, 0.843 and 0.846, respectively) significantly outperformed aspartate transaminase-to-platelet ratio (APRI) (Obuchowski index, 0.651; p < .001) and fibrosis-4 index (FIB-4) (Obuchowski index, 0.676; p < .001) for staging liver fibrosis. Using the cutoffs, R-fibrosis and R-score had a sensitivity range of 70–87%, specificity range of 71–97%, and accuracy range of 82–86% in diagnosing significant fibrosis, advanced fibrosis and cirrhosis. Conclusion Radiomic analysis of contrast-enhanced CT images can reach great diagnostic performance of liver fibrosis.

gastroenterology & hepatology
Staging liver fibrosis: comparison of radiomics model and fusion model based on multiparametric MRI in patients with chronic liver disease

Huang, Baoxiang,Li, Zhiming

DOI: https://doi.org/10.1007/s00261-023-04142-2

IF: 2.4

2024-01-15

Abdominal Radiology

Abstract:To develop and compare radiomics model and fusion model based on multiple MR parameters for staging liver fibrosis in patients with chronic liver disease.

radiology, nuclear medicine & medical imaging
Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Zhiming Li,Jihong Sun,Xiaoming Yang

DOI: https://doi.org/10.1155/2015/595467

2015-01-01

BioMed Research International

Abstract:Liver fibrosis is a life-threatening disease with high morbidity and mortality owing to its diverse causes. Liver biopsy, as the current gold standard for diagnosing and staging liver fibrosis, has a number of limitations, including sample variability, relatively high cost, an invasive nature, and the potential of complications. Most importantly, in clinical practice, patients often reject additional liver biopsies after initiating treatment despite their being necessary for long-term follow-up. To resolve these problems, a number of different noninvasive imaging-based methods have been developed for accurate diagnosis of liver fibrosis. However, these techniques only reflect morphological or perfusion-related alterations in the liver, and thus they are generally only useful for the diagnosis of late-stage liver fibrosis (liver cirrhosis), which is already characterized by "irreversible" anatomic and hemodynamic changes. Thus, it is essential that new approaches are developed for accurately diagnosing early-stage liver fibrosis as at this stage the disease may be "reversed" by active treatment. The development of molecular MR imaging technology has potential in this regard, as it facilitates noninvasive, target-specific imaging of liver fibrosis. We provide an overview of recent advances in molecular MR imaging for the diagnosis and staging of liver fibrosis and we compare novel technologies with conventional MR imaging techniques.
Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T 1 ‐Weighted Imaging: Comparison of Different Radiomics Models

Ming Ni,Lili Wang,Haiyang Yu,Xiaoyi Wen,Yinghua Yang,Guangzhen Liu,Yabin Hu,Zhiming Li

DOI: https://doi.org/10.1002/jmri.27391

IF: 4.4

2020-10-12

Journal of Magnetic Resonance Imaging

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Liver fibrosis is a common process resulting from various etiologies. Sustained progression of liver fibrosis leads to cirrhosis, even hepatocellular carcinoma. Thus, noninvasive staging of liver fibrosis is of clinical importance. Radiomics is an emerging approach for staging liver fibrosis. However, the feature selection methods and classifier models are complicated, and may result in a discrepancy of diagnostic performance owing to different radiomics models.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To identify the optimal feature selection and classifier methods for predicting liver fibrosis by using nonenhanced T<sub>1</sub>‐weighted imaging. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Prospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Animal Model</h3><p>Wistar rats, total 97.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3T, 3D T<sub>1</sub>‐weighted images with fast‐spoiled gradient echo (FSPGR). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Liver fibrosis rats were induced via subcutaneous injection of a mixture of carbon tetrachloride. Rats in the control group were injected with saline. Segmentation and feature extraction were performed by 3D slicer and the image biomarker explorer (IBEX) software package. Data preprocessing, feature selection, model building, and model comparative evaluation were conducted with Python. The liver fibrosis stage was determined by pathological examination.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Receiver operating characteristic curve, fuzzy comprehensive evaluation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>For discriminating between F0 and F1‐2, F0 and F3‐4, F0 and F1‐4, F0‐1 and F2‐4, F0‐2 and F3‐4, and F0‐3 and F4, the accuracies of 12 radiomics models were 77.27–90.91%, 73.33–86.67%, 80.56–91.67%, 74.07–88.89%, 76.47–88.24%, and 79.49–92.31%, respectively. The AUCs of the radiomics models were 0.86–0.97, 0.85–0.95, 0.89–0.97, 0.81–0.96, 0.82–0.93, and 0.85–0.96, respectively. The least absolute shrinkage and selection operator / support vector machine (LASSO‐SVM) model had high AUCs of 0.93–0.97. For discriminating between F0 and F1‐2, F0 and F3‐4, F0 and F1‐4, F0‐1 and F2‐4, and F0‐2 and F3‐4, the fuzzy comprehensive evaluation showed that the LASSO‐SVM model had a high fuzzy score/order of 0.087–0.091/1.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>LASSO‐SVM appears to be the optimal model for predicting liver fibrosis by using nonenhanced T<sub>1</sub>‐weighted imaging in a rodent model of liver fibrosis. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>2.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2.</p></section>

radiology, nuclear medicine & medical imaging
Imaging-Based Staging of Hepatic Fibrosis in Patients with Hepatitis B: A Dynamic Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI

Rencheng Zheng,Chunzi Shi,Chengyan Wang,Nannan Shi,Tian Qiu,Weibo Chen,Yuxin Shi,He Wang

DOI: https://doi.org/10.3390/biom11020307

IF: 6.064

2021-01-01

Biomolecules

Abstract:Accurate grading of liver fibrosis can effectively assess the severity of liver disease and help doctors make an appropriate diagnosis. This study aimed to perform the automatic staging of hepatic fibrosis on patients with hepatitis B, who underwent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging with dynamic radiomics analysis. The proposed dynamic radiomics model combined imaging features from multi-phase dynamic contrast-enhanced (DCE) images and time-domain information. Imaging features were extracted from the deep learning-based segmented liver volume, and time-domain features were further explored to analyze the variation in features during contrast enhancement. Model construction and evaluation were based on a 132-case data set. The proposed model achieved remarkable performance in significant fibrosis (fibrosis stage S1 vs. S2-S4; accuracy (ACC) = 0.875, area under the curve (AUC) = 0.867), advanced fibrosis (S1-S2 vs. S3-S4; ACC = 0.825, AUC = 0.874), and cirrhosis (S1-S3 vs. S4; ACC = 0.850, AUC = 0.900) classifications in the test set. It was more dominant compared with the conventional single-phase or multi-phase DCE-based radiomics models, normalized liver enhancement, and some serological indicators. Time-domain features were found to play an important role in the classification models. The dynamic radiomics model can be applied for highly accurate automatic hepatic fibrosis staging.
Radiomics in the Diagnosis and Treatment of Hepatocellular Carcinoma

Chun Jiang,Yi-Qi Cai,Jia-Jia Yang,Can-Yu Ma,Jia-Xi Chen,Lan Huang,Ze Xiang,Jian Wu

DOI: https://doi.org/10.1016/j.hbpd.2023.03.010

2023-01-01

Abstract:Hepatocellular carcinoma (HCC) is a common malignant tumor. At present, early diagnosis of HCC is difficult and therapeutic methods are limited. Radiomics can achieve accurate quantitative evaluation of the lesions without invasion, and has important value in the diagnosis and treatment of HCC. Radiomics features can predict the development of cancer in patients, serve as the basis for risk stratification of HCC patients, and help clinicians distinguish similar diseases, thus improving the diagnostic accuracy. Furthermore, the prediction of the treatment outcomes helps determine the treatment plan. Radiomics is also helpful in predicting the HCC recurrence, disease-free survival and overall survival. This review summarized the role of radiomics in the diagnosis, treatment and prognosis of HCC.
Usefulness of Noncontrast MRI-Based Radiomics Combined Clinic Biomarkers in Stratification of Liver Fibrosis

Ru Zhao,Hong Zhao,Ya-Qiong Ge,Fang-Fang Zhou,Long-Sheng Wang,Hong-Zhen Yu,Xi-Jun Gong

DOI: https://doi.org/10.1155/2022/2249447

2022-06-21

Abstract:Purpose: To develop and validate a radiomic nomogram based on texture features from out-of-phase T1W images and clinical biomarkers in prediction of liver fibrosis. Materials and methods: Patients clinically diagnosed with chronic liver fibrosis who underwent liver biopsy and noncontrast MRI were enrolled. All patients were assigned to the nonsignificant fibrosis group with fibrosis stage <2 and the significant fibrosis group with stage ≥2. Texture parameters were extracted from out-of-phase T1-weighted (T1W) images and calculated using the Artificial Intelligent Kit (AK). Boruta and LASSO regressions were used for feature selection and a multivariable logistic regression was used for construction of a combinational model integrating radiomics and clinical biomarkers. The performance of the models was assessed by using the receiver operator curve (ROC) and decision curve. Results: ROC analysis of the radiomics model that included the most discriminative features showed AUCs of the training and test groups were 0.80 and 0.78. A combinational model integrating RADscore and fibrosis 4 index was established. ROC analysis of the training and test groups showed good to excellent performance with AUC of 0.93 and 0.86. Decision curves showed the combinational model added more net benefit than radiomic and clinical models alone. Conclusions: The study presents a combinational model that incorporates RADscore and clinical biomarkers, which is promising in classification of liver fibrosis.
Polarization imaging-based radiomics approach for the staging of liver fibrosis

Yue Yao,Fengdi Zhang,Bin Wang,Jiachen Wan,Lu Si,Yang Dong,Yuanhuan Zhu,Xiaolong Liu,Lihong Chen,Hui Ma

DOI: https://doi.org/10.1364/boe.450294

IF: 3.4

2022-02-18

Biomedical Optics Express

Abstract:Mueller matrix imaging contains abundant biological microstructure information and has shown promising potential in clinical applications. Compared with the ordinary unpolarized light microscopy that relies on the spatial resolution to reveal detailed histological features, Mueller matrix imaging encodes rich information on the microstructures even at low-resolution and wide-field conditions. Accurate staging of liver fibrosis is essential for the therapeutic diagnosis and prognosis of chronic liver diseases. In the clinic, pathologists commonly use semiquantitative numerical scoring systems to determine the stages of liver fibrosis based on the visualization of stained characteristic morphological changes, which require skilled staining technicians and well-trained pathologists. A polarization imaging based quantitative diagnostic method can help to reduce the time-consuming multiple staining processes and provide quantitative information to facilitate the accurate staging of liver fibrosis. In this study, we report a polarization imaging based radiomics approach to provide quantitative diagnostic features for the staging of liver fibrosis. Comparisons between polarization image features under a 4× objective lens with H&E image features under 4×, 10×, 20×, and 40× objective lenses were performed to highlight the superiority of the high dimensional polarization image features in the characterization of the histological microstructures of liver fibrosis tissues at low-resolution and wide-field conditions.

radiology, nuclear medicine & medical imaging,biochemical research methods,optics
Effects of slice thickness on CT radiomics features and models for staging liver fibrosis caused by chronic liver disease

Peng Hu,Liye Chen,Yaoying Zhong,Yudong Lin,Xiaojing Yu,Xi Hu,Xinwei Tao,Shushen Lin,Tianye Niu,Ran Chen,Xia Wu,Jihong Sun

DOI: https://doi.org/10.1007/s11604-022-01284-z

2022-05-08

Japanese Journal of Radiology

Abstract:Objectives To investigate the effects of slice thickness on CT radiomics features and models for staging liver fibrosis. Methods A total of 108 pathologically confirmed liver fibrosis patients from a single center were retrospectively collected and divided into different groups. Both thick (5- or 7-mm) and thin slices (1.3- or 2-mm) were analyzed. A fivefold cross-validation with 100 repeats was conducted. The minimum redundancy–maximum relevance algorithm was used to reduce the radiomics features, and the top 10 ranking features were included for further analysis for each loop. The random forest was used for model establishment. The models with median AUC were selected for the assessment of the discriminative performance for both datasets. Mutual features selected by the models with AUC > 0.8 were searched and considered as the most predictive ones. Results A total of 162 and 643 radiomics features with excellent reliability were selected from thick- and thin-slice datasets, respectively. The overall discriminative performance of the 500 AUCs from the thin-slice dataset was better than the thick slice. The median AUC values of the thick-sliced datasets were significantly lower than those of the thin-sliced datasets (0.78 and 0.90 for differentiating F1 vs. F2–4, 0.72 and 0.85 for differentiating F1–2 vs. F3–4, both P = 0.03). For differentiating F1–3 vs. F4, no significant difference was found (0.85 vs 0.94, P = 0.15). Six mutual predictive features across all the datasets were found. Conclusions The radiomics features extracted from thin-slice images and their corresponding models were better and more stable for staging liver fibrosis.

radiology, nuclear medicine & medical imaging
Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Zhiming Li,Jihong Sun,Lumin Chen,Ning Huang,Peng Hu,Xi Hu,Guocan Han,Yurong Zhou,Weixian Bai,Tianye Niu,Xiaoming Yang

DOI: https://doi.org/10.1002/jmri.25132

IF: 4.4

2015-01-01

Journal of Magnetic Resonance Imaging

Abstract:Purpose(:) To evaluate the pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in diagnosing and staging liver fibrosis in rabbits.Materials and Methods: DCE-MRI with gadodiamide (Gd-DTPA-BMA) was performed on a 3.0 Tesla, 60cm bore MR scanner for rabbits with CCl4-induced liver fibrosis, and an untreated control group. Fibrosis was staged according to the METAVIR system: control (F0; n=13), nonadvanced fibrosis (F1-2; n=15), and advanced fibrosis (F3-4; n=12). The DCE-MRI parameters K-trans, k(ep), V-e, and v(p) were measured with a dual-input extended Tofts model. Receiver operating characteristic analyses were performed to assess the diagnostic performance of K-trans, V-e, and v(p) in staging liver fibrosis.Results: Both K-trans and V-e decreased with increasing fibrosis stage. K-trans of the control group was significantly different from that of the overall fibrosis group, nonadvanced group, and advanced group (P < 0.001 for all). Significant differences were found between V-e of the control group and that of the overall fibrosis and advanced groups (P=0.019 and P=0.009, respectively). For K-trans, the areas under the receiver operating characteristic curve (AUROCs) for discriminating the control group from the overall fibrosis and advanced fibrosis groups were 0.909 (95% confidence interval [CI], 0.809-1.000), and 0.936 (95% CI, 0.847-1.000), respectively. For discriminating between the control and nonadvanced fibrosis groups, the AUROC of K-trans was 0.887 (95% CI, 0.762-1.000). The AUROCs of K-trans were higher than those of V-e and v(p) for discriminating between the control and overall fibrosis groups, the control and nonadvanced fibrosis groups, and the control and advanced fibrosis groups. Pharmacokinetic parameters were negatively correlated with fibrosis stage (K-trans, rho=-0.668, P < 0.001; V-e, rho=-0.438, P=0.005; v(p), rho=-0.360, P=0.023).Conclusion: Among pharmacokinetic parameters of DCE-MRI in our study, K-trans was an excellent predictor for differentiating fibrotic livers from normal livers, and differentiating normal livers from nonadvanced or advanced fibrosis livers.
A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease

Maowen Tang,Yuhui Wu,Na Hu,Chong Lin,Jian He,Xing Xia,Meihua Yang,Pinggui Lei,Peng Luo

DOI: https://doi.org/10.1038/s41598-024-70891-9

2024-08-30

Abstract:A combined model was developed using contrast-enhanced CT-based radiomics features and clinical characteristics to predict liver fibrosis stages in patients with chronic liver disease (CLD). We retrospectively analyzed multiphase CT scans and biopsy-confirmed liver fibrosis. 160 CLD patients were randomly divided into 7:3 training/validation ratio. Clinical laboratory indicators associated with liver fibrosis were identified using Spearman's correlation and multivariate logistic regression correlation. Radiomic features were extracted after segmenting the entire liver from multiphase CT images. Feature dimensionality reduction was performed using RF-RFE, LASSO, and mRMR methods. Six radiomics-based models were developed in the training cohort of 112 patients. Internal validation was conducted on 48 randomly assigned patients. Receptor Operating Characteristic (ROC) curves and confusion matrices were constructed to evaluate model performance. The radiomics model exhibited robust performance, with AUC values of 0.810 to 1.000 for significant fibrosis, advanced fibrosis, and cirrhosis. The integrated clinical-radiomics model had superior diagnostic efficacy in the validation cohort, with AUC values of 0.836 to 0.997. Moreover, these models outperformed established biomarkers such as the aspartate aminotransferase to platelet ratio index (APRI) and the fibrosis 4 score (FIB-4), as well as the gamma glutamyl transpeptidase to platelet ratio (GPR), in predicting the fibrotic stages. The clinical-radiomics model holds considerable promise as a non-invasive diagnostic tool for the assessment and staging of liver fibrosis in the patients with CLD, potentially leading to better patient management and outcomes.
Radiomic features at Contrast-enhanced CT Predict Virus-driven Liver Fibrosis: A Multi-institutional Study

Jincheng Wang,Shengnan Tang,Jin Wu,Shanshan Xu,Qikai Sun,Zheyu Zhou,Xiaoliang Xu,Yang Liu,Qiaoyu Liu,Yingfan Mao,Jian He,Xudong Zhang,Yin Yin

DOI: https://doi.org/10.14309/ctg.0000000000000712

2024-05-28

Clinical and Translational Gastroenterology

Abstract:Background: Liver fibrosis is a major cause of morbidity and mortality among in chronic hepatitis patients. Radiomics, particularly of the spleen, may improve diagnostic accuracy and treatment strategies. External validations are necessary to ensure reliability and generalizability. Methods: In this retrospective study, we developed three radiomics models using contrast-enhanced CT scans from 167 patients with liver fibrosis (training group) between January 2020 and December 2021. Radiomic features were extracted from arterial venous, portal venous, and equilibrium phase images. Recursive feature selection random forest (RFS-RF) and the least absolute shrinkage and selection operator (LASSO) logistic regression were used for feature selection and dimensionality reduction. Performance was assessed by area under the curve, C-index, calibration plots and decision curve analysis. External validation was performed on 114 patients from two institutions. Results: Twenty-five radiomic features were significantly associated with fibrosis stage, with 80% of the top 10 features originating from portal venous phase spleen images. The radiomics models showed good performance in the validation cohort (C-indices: 0.723-0.808) and excellent calibration. Decision curve analysis indicated clinical benefits, with machine learning-based radiomics models (RFR-score and SVMR-score) providing more significant advantages. Conclusion: Radiomic features offer significant benefits over existing serum indices for staging virus-driven liver fibrosis, underscoring the value of radiomics in enhancing diagnostic accuracy. Specifically, radiomics analysis of the spleen presents additional noninvasive options for assessing fibrosis, highlighting its potential in improving patient management and outcomes.

gastroenterology & hepatology
[Functional MR Study of Hepatic Fibrosis].

Liu-hong Wang,Min-ming Zhang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2010.02.017

2010-01-01

Abstract:The accurate diagnosis and staging of hepatic fibrosis is crucial for treatment and prognosis of liver disease. The current gold standard is liver biopsy, but it cannot be used in population-based screening, and has well known drawbacks if used for monitoring of disease progression or treatment results. Functional MR, as a non-invasive method, is increasingly used in hepatic fibrosis and became the current hot spot. Most recently available functional MR imaging techniques including diffusion weighted imaging, perfusion weighted imaging and MR spectroscopy can detect cirrhosis or fibrosis reasonably accurately. However, to date only MR elastography has been able to stage fibrosis or diagnose mild disease. MR diffusion weighted appears next most promising.
Liver Fibrosis Assessment Using Radiomics of Ultrasound Homodyned-K imaging Based on the Artificial Neural Network Estimator

Zhuhuang Zhou,Zijing Zhang,Anna Gao,Dar-In Tai,Shuicai Wu,Po-Hsiang Tsui

DOI: https://doi.org/10.1177/01617346221120070

Abstract:The homodyned-K distribution is an important ultrasound backscatter envelope statistics model of physical meaning, and the parametric imaging of the model parameters has been explored for quantitative ultrasound tissue characterization. In this paper, we proposed a new method for liver fibrosis characterization by using radiomics of ultrasound backscatter homodyned-K imaging based on an improved artificial neural network (iANN) estimator. The iANN estimator was used to estimate the ultrasound homodyned-K distribution parameters k and α from the backscattered radiofrequency (RF) signals of clinical liver fibrosis (n = 237), collected with a 3-MHz convex array transducer. The RF data were divided into two groups: Group I corresponded to liver fibrosis with no hepatic steatosis (n = 94), and Group II corresponded to liver fibrosis with mild to severe hepatic steatosis (n = 143). The estimated homodyned-K parameter values were then used to construct k and α parametric images using the sliding window technique. Radiomics features of k and α parametric images were extracted, and feature selection was conducted. Logistic regression classification models based on the selected radiomics features were built for staging liver fibrosis. Experimental results showed that the proposed method is overall superior to the radiomics method of uncompressed envelope images when assessing liver fibrosis. Regardless of hepatic steatosis, the proposed method achieved the best performance in staging liver fibrosis ≥F1, ≥F4, and the area under the receiver operating characteristic curve was 0.88, 0.85 (Group I), and 0.85, 0.86 (Group II), respectively. Radiomics has improved the ability of ultrasound backscatter statistical parametric imaging to assess liver fibrosis, and is expected to become a new quantitative ultrasound method for liver fibrosis characterization.
Multiparametric MRI-based whole-liver radiomics for predicting early-stage liver fibrosis in rabbits

Xiao-Fei Mai,Hao Zhang,Yang Wang,Wen-Xin Zhong,Li-Qiu Zou

DOI: https://doi.org/10.1093/bjr/tqae063

2024-03-29

British Journal of Radiology

Abstract:Abstract Objectives To develop and validate a whole-liver radiomic model using multiparametric magnetic resonance imaging (MRI) for predicting early-stage liver fibrosis (LF) in rabbits. Materials and Methods A total of 134 rabbits (early-stage LF, n = 91; advanced-stage LF, n = 43) who underwent liver magnetic resonance elastography (MRE), hepatobiliary phase (HBP), dynamic contrast enhanced (DCE), intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI) and T2* scanning were enrolled and randomly allocated to either the training or validation cohort. Whole-liver radiomic features were extracted and selected to develop a radiomic model and generate quantitative Rad-scores. Then, multivariable logistic regression was utilized to determine the Rad-scores associated with early-stage LF, and effective features were integrated to establish a combined model. The predictive performance was assessed by the area under the curve (AUC). Results The MRE model achieved superior AUCs of 0.95 in the training cohort and 0.86 in the validation cohort, followed by the DCE-MRI model (0.93 and 0.82), while the IVIM model had lower AUC values of 0.91 and 0.82, respectively. The Rad-scores of MRE, DCE-MRI and IVIM were identified as independent predictors associated with early-stage LF. The combined model demonstrated AUC values of 0.96 and 0.88 for predicting early-stage LF in the training and validation cohorts, respectively. Conclusions Our study highlights the remarkable performance of a multiparametric MRI-based radiomic model for the individualized diagnosis of early-stage LF. Advances in knowledge This is the first study to develop a combined model by integrating multiparametric radiomic features to improve the accuracy of LF staging.

radiology, nuclear medicine & medical imaging
Combining Hepatic and Splenic CT Radiomic Features Improves Radiomic Analysis Performance for Liver Fibrosis Staging

Yunchao Yin,Derya Yakar,Rudi A. J. O. Dierckx,Kim B. Mouridsen,Thomas C. Kwee,Robbert J. de Haas

DOI: https://doi.org/10.3390/diagnostics12020550

IF: 3.6

2022-02-21

Diagnostics

Abstract:Background: The exact focus of computed tomography (CT)-based artificial intelligence techniques when staging liver fibrosis is still not exactly known. This study aimed to determine both the added value of splenic information to hepatic information, and the correlation between important radiomic features and information exploited by deep learning models for liver fibrosis staging by CT-based radiomics. Methods: The study design is retrospective. Radiomic features were extracted from both liver and spleen on portal venous phase CT images of 252 consecutive patients with histologically proven liver fibrosis stages between 2006 and 2018. The radiomics analyses for liver fibrosis staging were done by hepatic and hepatic–splenic features, respectively. The most predictive radiomic features were automatically selected by machine learning models. Results: When using splenic–hepatic features in the CT-based radiomics analysis, the average accuracy rates for significant fibrosis, advanced fibrosis, and cirrhosis were 88%, 82%, and 86%, and area under the receiver operating characteristic curves (AUCs) were 0.92, 0.81, and 0.85. The AUC of hepatic–splenic-based radiomics analysis with the ensemble classifier was 7% larger than that of hepatic-based analysis (p < 0.05). The most important features selected by machine learning models included both hepatic and splenic features, and they were consistent with the location maps indicating the focus of deep learning when predicting liver fibrosis stage. Conclusions: Adding CT-based splenic radiomic features to hepatic radiomic features increases radiomics analysis performance for liver fibrosis staging. The most important features of the radiomics analysis were consistent with the information exploited by deep learning.

medicine, general & internal
Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Wenpeng Huang,Yushuo Peng,Lei Kang

DOI: https://doi.org/10.1002/VIW.20240010

2024-01-01

View

Abstract:Abstract Liver fibrosis is a reparative response triggered by liver injury. Non‐invasive assessment and staging of liver fibrosis in patients with chronic liver disease are of paramount importance, as treatment strategies and prognoses depend significantly on the degree of fibrosis. Although liver fibrosis has traditionally been staged through invasive liver biopsy, this method is prone to sampling errors, particularly when biopsy sizes are inadequate. Consequently, there is an urgent clinical need for an alternative to biopsy, one that ensures precise, sensitive, and non‐invasive diagnosis and staging of liver fibrosis. Non‐invasive imaging assessments have assumed a pivotal role in clinical practice, enjoying growing popularity and acceptance due to their potential for diagnosing, staging, and monitoring liver fibrosis. In this comprehensive review, we first delved into the current landscape of non‐invasive imaging technologies, assessing their accuracy and the transformative impact they have had on the diagnosis and management of liver fibrosis in both clinical practice and animal models. Additionally, we provided an in‐depth exploration of recent advancements in ultrasound imaging, computed tomography imaging, magnetic resonance imaging, nuclear medicine imaging, radiomics, and artificial intelligence within the field of liver fibrosis research. We summarized the key concepts, advantages, limitations, and diagnostic performance of each technique. Finally, we discussed the challenges associated with clinical implementation and offer our perspective on advancing the field, hoping to provide alternative directions for the future research.
Radiobioinformatics: A Novel Bridge Between Basic Research and Clinical Practice for Clinical Decision Support in Diffuse Liver Diseases

Pinggui Lei,Na Hu,Yuhui Wu,Maowen Tang,Chong Lin,Luoyi Kong,Lingfeng Zhang,Peng Luo,Lawrence Wing‐Chi Chan

DOI: https://doi.org/10.1002/ird3.24

2023-01-01

Abstract:Abstract The liver is a multifaceted organ that is responsible for many critical functions encompassing amino acid, carbohydrate, and lipid metabolism, all of which make a healthy liver essential for the human body. Contemporary imaging methodologies have remarkable diagnostic accuracy in discerning focal liver lesions; however, a comprehensive understanding of diffuse liver diseases is a requisite for radiologists to accurately diagnose or predict the progression of such lesions within clinical contexts. Nonetheless, the conventional attributes of radiological features, including morphology, size, margin, density, signal intensity, and echoes, limit their clinical utility. Radiomics is a widely used approach that is characterized by the extraction of copious image features from radiographic depictions, which gives it considerable potential in addressing this limitation. It is worth noting that functional or molecular alterations occur significantly prior to the morphological shifts discernible by imaging modalities. Consequently, the explication of potential mechanisms by multiomics analyses (encompassing genomics, epigenomics, transcriptomics, proteomics, and metabolomics) is essential for investigating putative signal pathway regulations from a radiological viewpoint. In this review, we elaborate on the principal pathological categorizations of diffuse liver diseases, the evaluation of multiomics approaches pertaining to diffuse liver diseases, and the prospective value of predictive models. Accordingly, the overarching objective of this review is to scrutinize the interrelations between radiological features and bioinformatics as well as to consider the development of prediction models predicated on radiobioinformatics as integral components of clinical decision support systems for diffuse liver diseases.
Application of radiomics approach for decoding normal liver features and predicting chemotherapy-associated liver injury:A preliminary study

Fan XIA,Panpan HU,Jiazhou WANG,Weigang HU,Guichao LI,Zhen ZHANG

DOI: https://doi.org/10.19401/j.cnki.1007-3639.2016.06.007

2016-01-01

Abstract:Background and purpose:Radiomics refers to the comprehensive quantification of human tissues through assessing a large number of quantitative image features. Radiomics approach is used to decode tumor phenotypes and predict treatment outcomes. Here we present a study investigating radiomic analysis to assess normal liver features and predict chemotherapy-associated liver injury.Methods:Gastric cancer patients treated with surgery and adjuvant chemotherapy were enrolled in this study retrospectively. CT images were obtained before chemotherapy. The whole liver organ was delineated by radiation oncologists. Images were extracted and filtered by radiomic approach to extract radiomic features. Clustering was performed to reveal clusters of patients with similar radiomic expression patterns. Chi-squared tests were used to assess the association of radiomic data with clinical data and chemotherapy-related liver injury.Results:Radiomic features of 73 patients were clustered into two clusters. A significant association with gender (P=0.004, chi-squared test) was observed, where in male showed a higher presence in cluster Ⅰ. Incidence of abnormal liver function after chemotherapy was 48.7% in cluster I and 67.6% in cluster Ⅱ, respectively (Δ=18.9%). Clinical data including age, gender, chemotherapy modality, number of chemotherapy cycles, HBV infection history, HBs-antigen presence were not associated with liver function abnormalities after chemotherapy. Accuracy of radiomic analysis to predict liver injury is 0.59.Conclusion:Radiomic approach revealed different imaging features of liver between men and women. It could help to predict chemotherapy-associated liver injury. It is feasible to use radiomics approach to decode normal liver features and predict treatment-associated liver injury.
Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study

Shengnan Tang,Jin Wu,Shanshan Xu,Qi Li,Jian He

DOI: https://doi.org/10.3389/fgene.2023.1071085

IF: 3.7

2023-03-21

Frontiers in Genetics

Abstract:Purpose: Our aim is to build and validate a clinical-radiomic model for non-invasive liver steatosis prediction based on non-contrast computed tomography (CT). Methods: We retrospectively reviewed 342 patients with suspected NAFLD diagnoses between January 2019 and July 2020 who underwent non-contrast CT and liver biopsy. Radiomics features from hepatic and splenic regions-of-interests (ROIs) were extracted based on abdominal non-contrast CT imaging. The radiomics signature was constructed based on reproducible features by adopting the least absolute shrinkage and selection operator (LASSO) regression. Then, multivariate logistic regression analysis was applied to develop a combined clinical-radiomic nomogram integrating radiomics signature with several independent clinical predictors in a training cohort of 124 patients between January 2019 and December 2019. The performance of models was determined by the area under the receiver operating characteristic curves and calibration curves. We conducted an internal validation during 103 consecutive patients between January 2020 and July 2020. Results: The radiomics signature was composed of four steatosis-related features and positively correlated with pathologic liver steatosis grade ( p < 0.01). In both subgroups (Group One, none vs . steatosis; Group Two, none/mild vs . moderate/severe steatosis), the clinical-radiomic model performed best within the validation cohort with an AUC of 0.734 and 0.930, respectively. The calibration curve confirmed the concordance of excellent models. Conclusion: We developed a robust clinical-radiomic model for accurate liver steatosis stage prediction in a non-invasive way, which may improve the clinical decision-making ability.

genetics & heredity

Role of radiomics in staging liver fibrosis: a meta-analysis

Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker

Staging liver fibrosis: comparison of radiomics model and fusion model based on multiparametric MRI in patients with chronic liver disease

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T 1 ‐Weighted Imaging: Comparison of Different Radiomics Models

Imaging-Based Staging of Hepatic Fibrosis in Patients with Hepatitis B: A Dynamic Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI

Radiomics in the Diagnosis and Treatment of Hepatocellular Carcinoma

Usefulness of Noncontrast MRI-Based Radiomics Combined Clinic Biomarkers in Stratification of Liver Fibrosis

Polarization imaging-based radiomics approach for the staging of liver fibrosis

Effects of slice thickness on CT radiomics features and models for staging liver fibrosis caused by chronic liver disease

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease

Radiomic features at Contrast-enhanced CT Predict Virus-driven Liver Fibrosis: A Multi-institutional Study

[Functional MR Study of Hepatic Fibrosis].

Liver Fibrosis Assessment Using Radiomics of Ultrasound Homodyned-K imaging Based on the Artificial Neural Network Estimator

Multiparametric MRI-based whole-liver radiomics for predicting early-stage liver fibrosis in rabbits

Combining Hepatic and Splenic CT Radiomic Features Improves Radiomic Analysis Performance for Liver Fibrosis Staging

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Radiobioinformatics: A Novel Bridge Between Basic Research and Clinical Practice for Clinical Decision Support in Diffuse Liver Diseases

Application of radiomics approach for decoding normal liver features and predicting chemotherapy-associated liver injury:A preliminary study

Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study